Suchergebnisse - "Shirabe, Ken"

PubPharm (122)

1

New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease

enthalten in: Journal of gastroenterology | 2023

von Uojima, H. | Nakabayashi, K. | Yamasaki, K. | +29

2

Phosphotungstic Acid-treated Picrosirius Red Staining Improves Whole-slide Quantitative Analysis of Collagen in Histological Specimens

enthalten in: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society | 2023

von Mukade, Y. | Kobayashi, S. | Nishijima, Y. | +6

3

Molecular and expressional characterization of tumor heterogeneity in pulmonary carcinosarcoma

enthalten in: Molecular carcinogenesis | 2022

von Ohtaki, Y. | Kawabata-Iwakawa, R. | Nobusawa, S. | +8

4

Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer

enthalten in: Scientific reports | 2022

von Kurozumi, S. | Kaira, K. | Matsumoto, H. | +15

5

Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung

enthalten in: Thoracic cancer | 2021

von Ohtaki, Y. | Kaira, K. | Yajima, T. | +11

6

Conophylline Inhibits Hepatocellular Carcinoma by Inhibiting Activated Cancer-associated Fibroblasts Through Suppression of G Protein-coupled Receptor 68

enthalten in: Molecular cancer therapeutics | 2021

von Yamanaka, T. | Harimoto, N. | Yokobori, T. | +13

7

Direct and Indirect Anticancer Activity of Plant-Derived Alkaloid Conophylline

enthalten in: Critical reviews in oncogenesis | 2021

von Umezawa, K. | Shirabe, K.

8

Phosphomolybdic Acid Prevents Nonspecific Nuclear Staining by Picrosirius Red but Is Converted to Molybdenum Blue by Blue Light

enthalten in: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society | 2020

von Hatori, M. | Moriya, S. | Fujimori, M. | +6

9

Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling

enthalten in: British journal of cancer | 2020

von Dolgormaa, G. | Harimoto, N. | Ishii, N. | +12

10

Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma : a retrospective in silico analysis of public datasets

enthalten in: Breast cancer research : BCR | 2020

von Kurozumi, S. | Alsaleem, M. | Monteiro, C. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]